Mangoselect®: Characterization, Pharmacokinetics and Bioavailability of Xanthone Metabolites
NCT ID: NCT04151641
Last Updated: 2020-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2019-11-11
2019-12-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The design of this study is a cross-over, double-blind and randomized trial on 10 healthy subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds
NCT02871596
Evaluation of Bioavailability of Phenolic Compounds From Oxxynea®
NCT03432104
Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes
NCT02293486
Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults
NCT04862338
Garcinia Mangostana L Rind and Solanum Lycopersicum Fructus Trial to Prevent Exercise-induced Oxidative Stress
NCT03899454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sequence 1
MNGDPF
Standardized mangosteen extract in dry powder form
MNGEF
Standardized mangosteen extract in encapsulated form
Sequence 2
MNGDPF
Standardized mangosteen extract in dry powder form
MNGEF
Standardized mangosteen extract in encapsulated form
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MNGDPF
Standardized mangosteen extract in dry powder form
MNGEF
Standardized mangosteen extract in encapsulated form
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stated willingness to comply with all the study procedures and availability for the duration of the study
* Male and female
* Normal BMI range (18.50-24.99)
* In good general health as evidenced by medical history
* Ability to take oral medication and be willing to adhere to lifestyle considerations
Exclusion Criteria
* Pregnancy or lactation
* Known allergic reaction to mangosteen
* Metabolic disorders or any kind of disease
* Currant smoker
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fytexia
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedro Alcaraz
Role: PRINCIPAL_INVESTIGATOR
UCAM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCAM
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MNGBDP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.